SCHEMBL5488862

SCHEMBL5488862

O=C(O)C(CI)c1ccc(O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 6/20 0.47
ESR2 Q92731 5/20 0.47
SRC P12931 1/20 0.46
LMNA P02545 2/20 0.43
HSD17B10 Q99714 1/20 0.43
SLC7A5 Q01650 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
ALDH1A1 P00352 2/20 0.41
GAA P10253 2/20 0.41
CYP2C19 P33261 2/20 0.40
TDP1 Q9NUW8 3/20 0.40
PTGS1 P23219 2/20 0.40
PTGS2 P35354 1/20 0.40
CPN1 P15169 1/20 0.40
CPB2 Q96IY4 1/20 0.40
POLB P06746 1/20 0.40
DRD1 P21728 2/20 0.39
CA2 P00918 2/20 0.39
CYP1A2 P05177 1/20 0.39
PGR P06401 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9702510 0.83 ESR1 (0.50) ESR1ESR2SRCLMNAHSD17B10
SCHEMBL1922327 0.83 CYP2C19 (0.57) SRCLMNAHSD17B10ALDH1A1CYP2C19
SCHEMBL7087165 0.81 ESR1 (0.48) ESR1ESR2SRCLMNAHSD17B10
SCHEMBL1118667 0.79 TAAR1 (0.52) ESR1ESR2SRCLMNAHSD17B10
SCHEMBL4795362 0.79 ESR1 (0.47) ESR1ESR2SRCLMNAHSD17B10
SCHEMBL819392 0.79 LMNA (0.61) ESR1ESR2SRCLMNAHSD17B10
SCHEMBL1118743 0.79 TAAR1 (0.52) ESR1ESR2SRCLMNAHSD17B10
SCHEMBL11248515 0.79 PTGS1 (0.61) ESR1ESR2SRCLMNAHSD17B10
SCHEMBL6461974 0.79 L3MBTL1 (0.62) ESR1ESR2SRCLMNAHSD17B10
SCHEMBL7040363 0.79 ESR1 (0.47) ESR1ESR2SRCLMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113402490-B Preparation method of 1,2,6, 7-tetrahydro-8H-indeno [5,4-b ] furan-8-one 白银京宇新药业有限公司 2023-01-03 CN disclosed
CN-113402490-A Preparation method of 1,2,6, 7-tetrahydro-8H-indeno [5,4-b ] furan-8-one 白银京宇新药业有限公司 2021-09-17 CN disclosed
EP-1783221-A1 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor MIGENIX Corp. (US) 2007-05-09 EP disclosed
US-7001729-B2 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor MIGENIX CORP. (US) 2006-02-21 US disclosed
US-6906175-B2 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor. MIGENIX CORP. (US) 2005-06-14 US disclosed
US-6902908-B2 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor MIGENIX CORP. (US) 2005-06-07 US disclosed
US-20050064530-A1 PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR MIGENIX CORP. 2005-03-24 US disclosed
US-20050019835-A1 PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR MIGENIX CORP. 2005-01-27 US disclosed
US-20050003353-A1 PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR MIGENIX CORP. 2005-01-06 US disclosed
US-20050003352-A1 PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR MIGENIX CORP. 2005-01-06 US disclosed
US-20040241801-A1 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor MITOKOR, INC. 2004-12-02 US disclosed
EP-1283884-A2 PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR MITOKOR (US) 2003-02-19 EP disclosed
US-20010044144-A1 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor MIGENIX CORP. 2001-11-22 US disclosed
WO-2000026370-A9 ADENINE NUCLEOTIDE TRANSLOCATOR (ANT) FUSION PROTEINS AND USES THEREOF MITOKOR (US) 2001-11-15 WO disclosed
WO-2001085944-A2 PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR MITOKOR (US) 2001-11-15 WO disclosed
EP-1049780-A1 ADENINE NUCLEOTIDE TRANSLOCATOR (ANT) FUSION PROTEINS AND USES THEREOF MITOKOR (US) 2000-11-08 EP disclosed
WO-2000026370-A2 ADENINE NUCLEOTIDE TRANSLOCATOR (ANT) FUSION PROTEINS AND USES THEREOF MITOKOR (US) 2000-05-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010044144-A1 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor GART, TMEM165, SLC43A3 ESR1 3311/4885ESR2 3727/4885SRC 4827/4885
US-20050003353-A1 PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR GART, TMEM165, SLC43A3 ESR1 3311/4885ESR2 3727/4885SRC 4827/4885
US-20040241801-A1 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor GART, TMEM165, SLC43A3 ESR1 3311/4885ESR2 3727/4885SRC 4827/4885
US-20050003352-A1 PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR GART, TMEM165, SLC43A3 ESR1 3311/4885ESR2 3727/4885SRC 4827/4885
US-20050064530-A1 PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR GART, TMEM165, SLC43A3 ESR1 3311/4885ESR2 3727/4885SRC 4827/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.